✦ LIBER ✦

Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7years

✍ Scribed by Kibel, A.S.

Book ID: 122361204
Publisher: Elsevier Science
Year: 2011
Weight: 46 KB
Volume: 2011
Category: Article
ISSN: 0084-4071
DOI: 10.1016/j.yuro.2011.05.059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiandrogen monotherapy in patients wit

Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years

✍ Peter Iversen; David G. McLeod; William A. See; Thomas Morris; Jon Armstrong; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

BICALUTAMIDE 150 MG IN ADDITION TO STAND

BICALUTAMIDE 150 MG IN ADDITION TO STANDARD CARE IN PATIENTS WITH LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM THE SECOND ANALYSIS OF THE EARLY PROSTATE CANCER PROGRAM AT MEDIAN FOLLOWUP OF 5.4 YEARS

✍ WIRTH, MANFRED P.; SEE, WILLIAM A.; McLEOD, DAVID G.; IVERSEN, PETER; MORRIS, TO 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 220 KB

Bicalutamide (‘Casodex’) 150 mg as

Bicalutamide (‘Casodex’) 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme

✍ Chris J. Tyrrell; Heather Payne; William A. See; David G. McLeod; Manfred P. Wir 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 245 KB

PS2 Late breaking Adding bicalutamide 15

PS2 Late breaking Adding bicalutamide 150mg to standard care for localised or locally advanced prostate cancer: results from the largest hormonal therapy trial ever conducted in prostate cancer patients, at over 7 years' follow up

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Casodex (bicalutamide) 150-mg monotherap

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

✍ Peter Iversen; Chris J. Tyrrell; Amir V. Kaisary; John B. Anderson; Luc Baert; T 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 871 KB